PRP intraovarian injection improves the number and quality of blastocysts in mouse models

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 17 on September 13, 2024, entitled, “Intraovarian PRP injection improves oocyte quality and early embryo development in mouse models of chemotherapy-induced diminished ovarian reserve.”

Pharmacosmos ventures into oncology and merges with G1 Therapeutics – Pharmaceutical Technology

The deal is centred around G1’s lead cyclin-dependent kinase 4/6 (CDK4/6) inhibitor Cosela (trilaciclib), which generated $46.3m in sales last year. Image Credit: Golden Sikorka

August 8, 2024

Opinion | ‘A Pain in the Ass’: What We Heard This Week

“It’s still a pain in the ass.” — Christie Ballantyne, MD, of Baylor College of Medicine in Houston, discussing how despite some improvements in access

April 15, 2024

Novel hMPV strains linked to rising respiratory infections in young children

Researchers in India discovered novel hMPV lineages A2.2.1 and A2.2.2, emphasizing their role in pediatric respiratory infections and potential public health implications.

January 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.